Jiaxun Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiaxun Liu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Amy B. W. Chan
Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, New Territories, Hong Kong
1 shared publication - Cherie Tsz-Yiu Law
School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China
1 shared publication - Chit Chow
Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China
1 shared publication - Jason Ying Kuen Chan
Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China
1 shared publication - Jinpao Hou
School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
1 shared publication - Judy Wai Ping Yam
Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China; State Key Laboratory of Liver Research (The University of Hong Kong), Hong Kong, China; Materials Innovation Institute for Life Sciences and Energy (MILES), HKU-SIRI, Shenzhen, China
1 shared publication
Latest Publications
- Open Access
The Role of Arginine Metabolism in Oral Tongue Squamous Cell Carcinoma
Early diagnosis and treatment do not prevent the high morbidity and poor prognosis of oral tongue squamous cell carcinoma (TSCC). Earlier studies have shown that ARG1 signaling is deregulated in TSCC. Here, we investigated the complexity of ARG1 metabolism in this cancer subsite to appreciate the therapeutic potential of this potential biological vulnerability. Various functional studies show that ARG1 overexpression in oral cancer cells inhibits cell proliferation and invasion compared with controls. Further, RNA-sequencing revealed numerous differentially expressed genes (DEGs) and associated networks were dysregulated by ARG1 overexpression, including hypoxia-inducible factor (HIFα) signaling, the natural killer cell signaling pathway and interferon signaling. Our work provides a foundation for understanding the mechanism of action of disrupted arginine metabolism in oral tongue squamous cell carcinoma. This may impact the community for developing further therapeutic approaches.
Open AccessThe Role of Arginine Metabolism in Oral Tongue Squamous Cell Carcinoma
Early diagnosis and treatment do not prevent the high morbidity and poor prognosis of oral tongue squamous cell carcinoma (TSCC). Earlier studies have shown that ARG1 signaling is deregulated in TSCC. Here, we investigated the complexity of ARG1 metabolism in this cancer subsite to appreciate the therapeutic potential of this potential biological vulnerability. Various functional studies show that ARG1 overexpression in oral cancer cells inhibits cell proliferation and invasion compared with controls. Further, RNA-sequencing revealed numerous differentially expressed genes (DEGs) and associated networks were dysregulated by ARG1 overexpression, including hypoxia-inducible factor (HIFα) signaling, the natural killer cell signaling pathway and interferon signaling. Our work provides a foundation for understanding the mechanism of action of disrupted arginine metabolism in oral tongue squamous cell carcinoma. This may impact the community for developing further therapeutic approaches.